RxDoctor Payments Data

Erin Siceloff, PA

Physician Assistant · Charlotte, NCNPI 1376564104

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Novartis at 57.3% of the total. 2025 is the largest year on record at $25,420, 4.2 times the $6,018 reported in 2021. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,946in general payments, 2019–2025

Across 529 payments — averaging $94.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$29K
  • Boehringer Ingelheim$8K
  • Amgen$2K
  • Pfizer$2K
  • UCB, Inc.$2K
  • AbbVie$2K
  • plus $5K from 20 others

What the payments were for

  • Consulting fees$20,49541%
  • Speaking & faculty fees$5,86012%
  • Travel & lodging$11,25123%
  • Food & beverage$12,21024%
  • Education$1310%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,946 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$59,115
Medicare patients
279
Services billed
2,526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept13$95,554
Hydroxychloroquine Sulfate210$7,108
MethotrexateMethotrexate Sodium143$3,545
Leflunomide39$2,170
Tramadol Hcl203$1,712
Prednisone292$1,482
Celecoxib67$1,272
Duloxetine Hcl55$826
Colchicine15$794
Etodolac24$746
Sulfasalazine32$633
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$551
Methylprednisolone34$418
Cyclobenzaprine Hcl23$362
Gabapentin24$293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Colchicine$21$79415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →